TELOGEN EFFLUVIUM

Clinical trials for TELOGEN EFFLUVIUM explained in plain language.

Never miss a new study

Get alerted when new TELOGEN EFFLUVIUM trials appear

Sign up with your email to follow new studies for TELOGEN EFFLUVIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 4

Hair loss hope: new drink targets shedding from popular Weight-Loss meds

Symptom relief Recruiting now

This study tests a daily drinkable supplement called Olistic Next Women to see if it can reduce hair loss in women over 35 who are taking GLP-1/GIP weight-loss drugs. Forty participants will be randomly assigned to receive either the supplement or a placebo for 6 months. The main…

Matched conditions: TELOGEN EFFLUVIUM

Phase: NA • Sponsor: Olistic Research Labs S.L. • Aim: Symptom relief

Last updated Jun 27, 2026 12:00 UTC

TELOGEN EFFLUVIUM

Get alerted when new TELOGEN EFFLUVIUM trials appear

Hair loss hope: new drink targets shedding from popular Weight-Loss meds